|
RARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.232000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.268200E-01 |
| Normal-vs-Stage2 |
3.936800E-01 |
| Normal-vs-Stage3 |
8.145800E-02 |
| Normal-vs-Stage4 |
3.232800E-01 |
| Stage1-vs-Stage2 |
5.193000E-01 |
| Stage1-vs-Stage3 |
7.585800E-02 |
| Stage1-vs-Stage4 |
4.654600E-01 |
| Stage2-vs-Stage3 |
4.683000E-01 |
| Stage2-vs-Stage4 |
8.203000E-01 |
| Stage3-vs-Stage4 |
7.007200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.527000E-01 |
| Normal-vs-AfricanAmerican |
5.826100E-02 |
| Normal-vs-Asian |
8.902000E-01 |
| Caucasian-vs-AfricanAmerican |
2.329400E-01 |
| Caucasian-vs-Asian |
6.878200E-01 |
| AfricanAmerican-vs-Asian |
3.850600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.197400E-01 |
| Normal-vs-Female |
1.121660E-02 |
| Male-vs-Female |
9.182900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.089200E-01 |
| Normal-vs-Extreme_Weight |
3.223200E-01 |
| Normal-vs-Obese |
8.213600E-02 |
| Normal-vs-Extreme_Obese |
8.177800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.529800E-01 |
| Normal_Weight-vs-Obese |
2.806000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.335200E-01 |
| Extreme_Weight-vs-Obese |
1.115780E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.615400E-01 |
| Obese-vs-Extreme_Obese |
6.030600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.627150E-01 |
| Normal-vs-Age(41-60Yrs) |
6.954000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.676000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.841800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.234600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.867420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.194400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.723240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.242550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.206600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.338200E-01 |
| Normal-VS-Type2 PRCC |
5.020800E-01 |
| Normal-VS-KIRP CIMP |
2.497900E-02 |
| Normal-VS-Unclassified PRCC |
6.740600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.296800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.037500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.102400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.125730E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.987000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.262700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.073400E-01 |
| Normal-vs-N1 |
2.216400E-02 |
| Normal-vs-N2 |
5.712300E-02 |
| N0-vs-N1 |
2.120300E-02 |
| N0-vs-N2 |
3.709800E-01 |
| N1-vs-N2 |
7.556000E-02 |
|
|
